Efficacy and safety of preterm formula supplemented with energy substrates for the nutrition of infants of very low birth weight
- Conditions
- Very low birth weightPregnancy and ChildbirthDisorders related to short gestation and low birth weight, not elsewhere classified
- Registration Number
- ISRCTN61070850
- Lead Sponsor
- ational Institute of Paediatrics (Instituto Nacional de Pediatria) (Mexico)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 63
1. Both male and female infants, aged less than 28 days
2. Hospitalised in the Intensive Care Unit (ICU) or Neonatal Intermediate Care Unit (NICU)
3. Weight less than 1500 g at birth
4. Fed exclusively via enteral route
5. Haemodynamic stability (arterio-venous 3 - 5)
6. Have not received prior formulas with added energy substrates
7. Signed informed consent by parents or guardians
1. Patients suffering from inborn errors of metabolism in any variant or a disease in itself a negative influence on growth (congenital heart disease, kidney failure, genetic diseases)
2. Post-operative state greater than 72 hours
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Number of days required to reach 1800 g in weight<br>2. Type of treatment administered<br>3. Weight<br>4. Height<br>5. Cephalic perimeter<br>6. Mid-arm circumference<br><br>Measured at 21 days.
- Secondary Outcome Measures
Name Time Method 1. Biochemical parameters: serum albumin, prealbumin, total protein, creatinine, blood-urea nitrogen (BUN), nitrogen balance<br>2. Security settings: abdominal perimeter, vomiting, stool consistency, temperature, blood in stools, serum glucose, calcium, phosphorus, magnesium, triglycerides<br><br>Measured at 21 days.